Patent Results

16 Results for: citation_id:3891625

Method Of Use Of Monomeric Insulin As A Means For Improving The Reproducibility Of Inhaled Insulin

  • Published: Feb 17, 2009
  • Family: 22
  • Cited: 4
  • Info: Full text Published
  • Owner: Aradigm Corporation, Novo Nordisk A/s

Insulin Delivery Enhanced By Coached Breathing

  • Published: Nov 18, 2003
  • Family: 7
  • Cited: 6
  • Info: Full text Published
  • Owner: Aradigm Corporation, Novo Nordisk A/s

Insulin Delivery Enhanced By Coached Breathing

  • Published: Jun 25, 2002
  • Family: 7
  • Cited: 17
  • Info: Full text Published
  • Owner: Aradigm Corporation, Novo Nordisk A/s

Insulin Delivery Enhanced By Coached Breathing

  • Published: Jul 11, 2000
  • Family: 7
  • Cited: 22
  • Info: Full text Published
  • Owner: Aradigm Corporation, Novo Nordisk A/s

Method Of Reproducibly Effecting A Patient's Glucose Level

  • Published: Aug 8, 2000
  • Family: 2
  • Cited: 18
  • Info: Full text Published
  • Owner: Aradigm Corporation, Novo Nordisk A/s

Creating An Aerosolized Formulation Of Insulin

Use Of Monomeric Insulin As A Means For Improving The Bioavailability Of Inhaled Insulin

Method Of Use Of Monomeric Insulin As A Means For Improving The Reproducibility Of Inhaled Insulin

Method Of Use Of Monomeric Insulin As A Means For Improving The Reproducibility Of Inhaled Insulin

Sign in to the Lens